Dr. Reddy’s to acquire Haleon’s global portfolio of consumer healthcare brands
Dr. Reddy's Laboratories Ltd. is acquiring Haleon's global portfolio of consumer healthcare brands in the Nicotine Replacement Therapy category, including Nicotinell. This acquisition will enhance Dr. Reddy's consumer healthcare OTC business and expand its reach in over 30 countries. The deal is expected to be finalized in early Q4 of 2024.